Tsubota Laboratory (TSE:4890) Net Margin %: -440.18% (As of Mar. 2026)


TSE:4890 Tsubota Laboratory Inc TSE:4890
63 GF Score
Price 円221.00
GF Value 円83.95
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Tsubota Laboratory Net Margin %?

Tsubota Laboratory TSE:4890 -0.45% 63 Net Margin % is -440.18% as of Mar. 2026. GuruFocus rates TSE:4890 with a GF Score™ of 63/100 and a GF Value™ of 円83.95 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Tsubota Laboratory ranks worse than 89.6% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Tsubota Laboratory's Net Income for the six months ended in Mar. 2026 was 円-428.0 Mil. Tsubota Laboratory's Revenue for the six months ended in Mar. 2026 was 円97.2 Mil. Therefore, Tsubota Laboratory's net margin for the quarter that ended in Mar. 2026 was -440.18%.

The historical rank and industry rank for Tsubota Laboratory's Net Margin % or its related term are showing as below:

TSE:4890' s Net Margin % Range Over the Past 10 Years
Min: -380.87   Med: 9.45   Max: 29.32
Current: -380.87


TSE:4890's Net Margin % is ranked worse than
89.6% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: 2.09 vs TSE:4890: -380.87

Tsubota Laboratory  (TSE:4890) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Tsubota Laboratory Net Margin % Related Terms


Tsubota Laboratory Net Margin % Historical Data

* Premium members only.

The historical data trend for Tsubota Laboratory's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsubota Laboratory Net Margin % Chart

Tsubota Laboratory Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial 23.92 9.45 -95.22 15.16 -380.87

Tsubota Laboratory Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -55.74 9.21 18.49 -324.76 -440.18

TSE:4890 vs ABT, SYK, MDT: Net Margin % Comparison

For the Medical Devices subindustry, Tsubota Laboratory's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsubota Laboratory Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tsubota Laboratory's Net Margin % distribution charts can be found below:

* The bar in red indicates where Tsubota Laboratory's Net Margin % falls into.


TSE:4890
63GF Score
Tsubota Laboratory Inc TSE:4890
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tsubota Laboratory Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Tsubota Laboratory's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-761.815/200.022
=-380.87 %

Tsubota Laboratory's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-428.004/97.234
=-440.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -440.18% mean?
Tsubota Laboratory (TSE:4890) has a Net Margin % of -440.18% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Tsubota Laboratory and its competitors. According to the industry distribution chart, Tsubota Laboratory ranks #732 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 89.6%.
Is Tsubota Laboratory's Net Margin % too high?
Tsubota Laboratory's current Net Margin % is -440.18%. Based on the distribution chart, Tsubota Laboratory ranks #732 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tsubota Laboratory has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tsubota Laboratory's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Tsubota Laboratory ranks #732 out of 817 companies for Net Margin %. This places Tsubota Laboratory in the lower half of its industry. The industry median Net Margin % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Tsubota Laboratory and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsubota Laboratory's current Net Margin % is -440.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsubota Laboratory stock overvalued right now?
Based on GuruFocus' analysis, Tsubota Laboratory (TSE:4890) is currently considered Significantly Overvalued. The stock's GF Value™ is 円83.95, compared to a current price of 円221.00 — trading 163.3% above its estimated fair value. The current Net Margin % is -440.18%. Tsubota Laboratory's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Tsubota Laboratory (TSE:4890), the current Net Margin % is -440.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tsubota Laboratory (TSE:4890) Overvalued in 2026?

Based on GuruFocus' analysis, Tsubota Laboratory stock appears to be overvalued. The current stock price of 円221.00 is trading 163.3% above its estimated GF Value™ of 円83.95. GuruFocus considers Tsubota Laboratory to be Significantly Overvalued.

Key valuation signals for TSE:4890:

  • Net Margin %: -440.18%
  • GF Value™: 円83.95 vs. price of 円221.00 (163.3% above fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the TSE:4890 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tsubota Laboratory Business Description

Address 34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
63GF Score

Get the complete analysis for TSE:4890

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円221.00
Price
円83.95
GF Value